Sorafenib
Skin reactions following off label use of sorafenib: 5 case reports
Case report
First Online:
Reference
- Kimura G, et al. Sorafenib as a potential strategy for refractory pulmonary arterial hypertension. Pulmonary Pharmacology and Therapeutics 44: 46-49, 14 Mar 2017. Available from: URL: http://doi.org/10.1016/j.pupt.2017.03.009 -JapanCrossRefPubMedGoogle Scholar
Copyright information
© Springer International Publishing AG 2017